CONYERS, GA / ACCESSWIRE / July 22, 2015 / GeckoSystems Intl. Corp. (OTC Pink: GOSY) (PINKSHEETS: GOSY) (http://www.geckosystems.com/), announced today that the company has begun the transfer of its AI mobile robot software to Fubright Communications Co, Ltd. This is to facilitate the integration with their “Ninnin Pepper” dementia software in order to enable a higher level of safety and cost effective utility for SoftBank’s Pepper. To that end the company’s BaseBot(tm) “Lou” was delivered to Fubright this week for their exclusive use. The BaseBot utilizes the company’s core SafePath(tm) “AI Mobile Robot Solutions for Safety, Security and Service(tm)”

“As a result of Fubright winning SoftBank’s Pepper robot software contest against several dozens of competitors late last year with a dementia care software app known as “Ninnin Pepper” and its synergy with our GeckoNav(tm) self guidance mobile robot software, the resulting personal robot will be the most advanced, cost effective and truly utilitarian mobile personal robot in the Pacific Rim. Upon completion of our Artificial Intelligence (AI) software integration, we expect Pepper robot sales to go from only a thousand per month, to several tens of thousands. No doubt Foxconn is prepared to manufacture those significantly higher volumes for SoftBank Robotics,” stated Martin Spencer, CEO, GeckoSystems.

Recently Fubright and the company agreed upon a licensing schedule that sets the royalty stream to GeckoSystems for the use of GeckoNav. It is nearly an order magnitude greater than what Microsoft receives from OEM’s per PC. It differs in that it is on an annual, per year basis to fit SoftBank’s pricing strategy in Japan. This business model is known as Software as a Service (SaaS).

As a long time Japanese agent of GeckoSystems, Mr. Katsuji Fujii is credited with these successful negotiations with and management of Fubright.

Fubright’s “Ninnin” AI software allows the Pepper robot to assist in waking up dementia patients and take their scheduled medicines on time. Pepper also reports to a doctor via Internet if the patient did not consume their pills. On a daily basis, the robot communicates with the patient by asking about their family to stimulate memory and the touch screen tablet on its chest has the capability to send and receive pictures and messages from a family member. (“Japanese humanoid robot called Pepper gets its own app”)

Recently, Fubright witnessed a live demonstration in Japan of GeckoNav and received training from another Japanese partner of GeckoSystems, iXs Research, in its operation. GeckoNav is portable and very little R&D will be required to migrate and integrate the Company’s flagship real time sense and avoid self-driving AI software to the Pepper robot that enables errand running, etc. with a “loose crowd” level of autonomy. Unless a personal robot has safe mobility and the ability to stay automatically (without human intervention) proximate to the care receiver, it’s utility and value proposition are both severely constrained since the robot can only converse, remind in a single fixed location, regardless of where in the home the care receiver may be.

Perhaps most noteworthy is SoftBank’s Pepper robot critical need for more application software to improve its value proposition, as discussed here: “Pepper is Getting Ready”. Fubright and GeckoSystems want to have their proprietary AI software on every Pepper robot sold in the world.

SoftBank is encouraging and seeking apps for their Pepper robot just as they seek apps for the smart phones they sell in Japan, and as Apple does for its smart phones. GeckoSystems’ AI mobile robot tech transfer to Fubright enables greater credibility, and acceptance by Japanese users for GeckoSystems and consequently enhances sales growth and licensing revenues for the company’s stockholders.

Presently the Pepper robot lacks the fundamental and necessary functionality to safely run errands and automatically follow the care receiver. Again, real time sense and avoid moving and/or unmapped obstacles is a functional deficiency that precludes the Pepper from fully exploiting Fubright’s win of SoftBank’s Pepper software contest with their “Ninnin Pepper” for aiding those challenged by dementia. This need coupled with the robustness, maturity and ease of migration of GeckoNav to the Pepper is why Fubright is partnering with GeckoSystems in the formation of a Special Project Team, or joint venture, to quickly, dramatically increase Pepper robot sales for SoftBank.

SoftBank is fully aware of the reality that the Japanese heath care insurance system decreed over a year ago that their insurance program would pay 90% of the monthly costs of providing personal mobile robots for eldercare. SoftBank has a billion dollar market opportunity to sell millions of Pepper robots in the next few years. Foxconn wishes to manufacture those millions of Pepper robots for the Japanese and Chinese markets. Alibaba wishes to distribute a Chinese version of the Pepper in China.

On June 20, SoftBank sold a month’s production of Peppers, (1,000 robots) in the first few minutes of being offered online. “SoftBank sells 1,000 units of its Pepper robot in first minute of online trade” Per their July 3 press release: “SoftBank to Offer 1,000 ‘Pepper’ Units on July 31”.

“Due to Fubright’s preeminent position and relationship with SoftBank Robotics, it is very satisfying to make this significant announcement. As would be expected at this time, we have other ongoing negotiations and receive unsolicited distributor and/or dealer inquiries not infrequently. After many years of patience by our current 1300+ stockholders, they can be assured that the present management continues to work to maximize their investments in GeckoSystems whether by organic growth or being acquired at a rewarding premium,” concluded Spencer.

Recent third party market research:

Service Robotics Market (Professional and Personal), by Application (Defense, Agriculture, Medical, Domestic & Entertainment), & by Geography – Analysis Forecast (2014 – 2020)

Robotic systems are looked at as the future assistants that are designed to help people to do what they want to do in a natural and spontaneous manner. Moreover, with the emergence of ubiquitous computing and communication environments, robots will be able to call upon an unlimited knowledge base and coordinate their activities with other devices and systems. Additionally, the growing spread of ubiquitous computing will lead to robot technologies being embedded into ubiquitous ICT networks to become human agents of physical actions, enhancing and extending the physical capabilities and senses.

The report focuses on giving a detailed view of the complete service robotics industry with regards to the professional and personal applications as well as the geography market. Apart from the market segmentation, the report also includes the critical market data and qualitative information for each product type along with the qualitative analysis; such as Porter’s five force analysis, market time-line analysis, industry breakdown analysis, and value chain analysis. The global service robotics market is estimated to reach up to $19.41 billion by 2020 growing at a CAGR of 21.5% from 2014 to 2020.

Global Service Robot Market 2014-2018: Key Vendors are GeckoSystem, Honda Motor, iRobot and Toyota Motor

Worldwide Service Robot Market 2018 Analysis & Forecasts Report

The report recognizes the following companies as the key players in the Global Service Robot Market: GeckoSystem Intl. Corp., Honda Motor Co. Ltd., iRobot Corp. and Toyota Motor Corp.

From Forbes:

Investors Take Note, The Next Big Thing Will Be Robots

BusinessInsider makes some key points:

* The multibillion-dollar global market for robotics, long dominated by industrial and logistics uses, has begun to see a shift toward new consumer and office applications. There will be a $1.5 billion market for consumer and business robots by 2019.

* The market for consumer and office robots will grow at a CAGR of 17% between 2014 and 2019, seven times faster than the market for manufacturing robots.

Note: BusinessInsider.com’s forecasts do not include pent up demand for family care social robots anywhere in the world.

About GeckoSystems:

GeckoSystems has been developing innovative robotic technologies for over fifteen years. It is CEO Martin Spencer’s dream to make people’s lives better through robotic technology.

An overview of GeckoSystems’ progress containing over 700 pictures and 120 videos can be found at http://www.geckosystems.com/timeline/.

These videos illustrate the development of the technology that makes GeckoSystems a world leader in Service Robotics development. Early CareBot prototypes were slower and frequently pivoted in order to avoid a static or dynamic obstacle; later prototypes avoided obstacles without pivoting. Current CareBots avoid obstacles with a graceful “bicycle smooth” motion. The latest videos also depict the CareBot’s ability to automatically go faster or slower depending on the amount of clutter (number of obstacles) within its field of view. This is especially important when avoiding moving obstacles in “loose crowd” situations like a mall or an exhibit area.

In addition to the timeline videos, GeckoSystems has numerous YouTube videos. The most popular of which are the ones showing room-to-room automatic self-navigation of the CareBot through narrow doorways and a hallway of an old 1954 home. You will see the CareBot slow down when going through the doorways because of their narrow width and then speed up as it goes across the relatively open kitchen area. There are also videos of the SafePath(tm) wheelchair, which is a migration of the CareBot AI centric navigation system to a standard power wheelchair, and recently developed cost effective depth cameras were used in this recent configuration. SafePath navigation is now available to OEM licensees and these videos show the versatility of GeckoSystems’ fully autonomous navigation solution.

GeckoSystems, Star Wars Technology

The company has successfully completed an Alpha trial of its CareBot personal assistance robot for the elderly. It was tested in a home care setting and received enthusiastic support from both caregivers and care receivers. The company believes that the CareBot will increase the safety and well being of its elderly charges while decreasing stress on the caregiver and the family.

CareBot has incorporated Microsoft Kinect depth cameras that result in a significant cost reduction.

Kinect Enabled Personal Robot video

Above, the CareBot demonstrates static and dynamic obstacle avoidance as it backs in and out of a narrow and cluttered alley. There is no joystick control or programmed path; movements are smoother that those achieved using a joystick control. GeckoNav creates three low levels of obstacle avoidance: reactive, proactive, and contemplative. Subsumptive AI behavior within GeckoNav enables the CareBot to reach its target destination after engaging in obstacle avoidance.

More information on the CareBot personal assistance robot:http://www.geckosystems.com/markets/CareBot.php.

GeckoSystems stock is quoted in the U.S. over-the-counter (OTC) markets under the ticker symbol GOSY. http://www.otcmarkets.com/stock/GOSY/quote

Here is a stock message board devoted to GOSY recommended by us: http://investorshangout.com/board/62282/Geckosystems+Intl+Co-GOSY.

GeckoSystems uses LinkedIn and Twitter as its primary social media site for investor updates.

Spencer’s LinkedIn.com profile
Spencer tweets as @GrandpaRobot

Safe Harbor:

Statements regarding financial matters in this press release other than historical facts are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Securities Litigation Reform Act of 1995. The Company intends that such statements about the Company’s future expectations, including future revenues and earnings, technology efficacy and all other forward-looking statements be subject to the Safe Harbors created thereby. The Company is a development stage firm that continues to be dependent upon outside capital to sustain its existence. Since these statements (future operational results and sales) involve risks and uncertainties and are subject to change at any time, the Company’s actual results may differ materially from expected results.

CONTACT:

Telephone:
Main number: +1 678-413-9236
Fax: +1 678-413-9247
Website: http://www.geckosystems.com/

SOURCE: GeckoSystems Intl. Corp.

ReleaseID: 430775

Preparing to Launch Triferic, the Only FDA Approved Treatment to Deliver Iron and Maintain Hemoglobin in Hemodialysis Patients; Report Available here: www.lifescicapital.com/equity-research/rockwell

NEW YORK, NY / ACCESSWIRE / July 22, 2015 / LifeSci Capital, LLC, a research-driven investment bank with deep domain expertise in the life sciences sector, today announced that it has initiated coverage of Rockwell Medical, Inc. (NasdaqGM: RMTI), an established commercial biopharmaceutical company offering innovative products and services for hemodialysis. The Company received FDA approval on January 26th for Triferic, the only treatment indicated to replace iron and maintain hemoglobin in hemodialysis patients. Triferic has the potential to transform iron management in dialysis, and is especially well positioned in the bundled payment system. Rockwell has an established core business as a leading supplier of concentrate solutions for dialysis.

Iron deficiency is a common consequence of dialysis treatment. Delivered via dialysate, Triferic is specifically designed to replace the 5-7 mg of iron that dialysis patients lose during each session. Triferic binds to apo-transferrin upon entering the blood and is transported to the bone marrow without increasing ferritin, similar to how the body uses dietary iron. This stands in contrast to the IV iron products that are associated with severe safety problems, leaving an unmet need among dialysis patients for iron maintenance therapy. Triferic was approved in January with a strong safety profile, including no anaphylaxis in more than 100,000 administrations. Triferic is expected to create a new paradigm for managing anemia in hemodialysis patients. It has an active Q-code for reimbursement that became effective on July 1.

In a 26 page Initiation Report LifeSci Capital explains Rockwell’s experience selling products into the dialysis market and how this positions Triferic and Calcitriol for commercial success. We examine the clinical data, competitive landscape, and market opportunity for the Triferic as the only FDA approved treatment to replace iron and maintain hemoglobin in hemodialysis patients.

Dr. Isaacson’s full Initiation Report, including important disclosures, is available to download at no cost at the LifeSci Capital website, www.lifescicapital.com/equity-research/. In addition to this Initiation Report, LifeSci Capital intends to provide ongoing coverage and event-based research updates on Rockwell Medical as developments occur.

The LifeSci Capital research team is led by Dr. Jerry Isaacson, an industry veteran with broad experience in biotechnology, having worked in both public and private biotech companies in areas ranging from medicinal chemistry and analytical chemistry to patents and investor/public relations. Dr. Isaacson holds a Bachelor of Arts degree in Chemistry from Harvard University and received his Ph.D. in Organic Chemistry from the University of California in San Diego.

About LifeSci Capital:

LifeSci Capital (Member: FINRA/SIPC) is a research-driven investment bank with deep domain expertise in the life sciences. Our service model as a boutique investment bank is unique in that we exclusively serve emerging life science companies that discover, develop, and commercialize innovative products. We view our clients as our partners, and we work closely with them to establish and execute their capital markets strategies. Our broadly-distributed equity research product is differentiated and provides a deep understanding of our clients’ businesses and the opportunities they are addressing. To learn more about LifeSci Capital, visit the company’s website, www.lifescicapital.com.

Analyst Contact:

Jerry Isaacson, Ph.D.
Phone: (646) 597-6991
Email: jisaacson@lifescicapital.com

SOURCE: LifeSci Capital, LLC

ReleaseID: 430752

Leader in Global Alternative Financing Announces Milestone Rebranding of United Kapital, Capiota, AmeriMerchant, AUSvance and True North Capital

MANCHESTER, ENGLAND/ ACCESSWIRE / July 22, 2015 / Capify, a leading alternative finance provider powered by a proprietary technology and analytics platform, today announced its global rebrand to become the most diverse, worldwide alternative SME financing platform. Headquartered in the UK from its Manchester office, Capify combines five previously separate companies, which were all founded by CEO David Goldin, including:

– United Kapital, founded in 2008 and operating in the UK, with headquarters in Greater Manchester, England
– Capiota, launched in 2013, which acts as United Kapital’s business loan product provider, with headquarters in Greater Manchester, England
– AmeriMerchant, founded in 2002 and operating in the US, with New York City headquarters
– AUSvance, founded in 2008 and operating in Australia, with headquarters in Parramatta, New South Wales
– True North Capital, founded in 2007 and operating in Canada, with headquarters in Toronto

The creation of Capify comes at a time of significant growth in the UK alternative financing sector. According to research by Nesta and the University of Cambridge*, the alternative finance market in the UK grew by 161% from 2013 to 2014, with the market estimated to be worth £1.74 billion in 2014. This marries with the growth of the UK client base for Capify, which now totals just over 5,000 fundings to companies, who have received approximately £75 million in financing. The international group has provided over £320 million to businesses and more than 24,000 fundings in all four countries, across 550 different industries ranging from retail, bars, restaurants and health services to manufacturer, distributors, ecommerce companies and service businesses. The industry in the UK alone is expected to be worth around £4.4 billion in 2015.

“This is an exciting time for UK businesses seeking added value in alternative financing,” said Tony Pegg, UK Managing Director of Capify. “The creation of Capify allows us to build on our UK number one position to offer even more flexibility and scalability to our customers, who often suffer from a lack of suitable banking products. By working with customers we help them choose suitable solutions that suit their business models and expansion plans.”

From today, Capify will serve as the international brand for a conglomerate of alternative financing solutions. This includes merchant cash advance and business loans and other working capital products to small and medium-sized businesses. Existing customers of United Kapital and Capiota will see no change in their existing financing deals.

Capify’s innovative merchant cash advance service works by providing capital to businesses that derive the majority of their income through credit card and debit card sales, which acts as an efficient alternative to traditional business loans. It works by a business selling a share of future credit card and debit card sales for a merchant cash advance (between £3,500 and £500,000). Repayments are made on an agreed fixed percentage of each credit or debit card transaction the business makes. This makes it efficient for businesses that are looking to grow or expand. There is also no early settlement fee and no fixed monthly repayment and the repayments are made only when the business is making sales.

Capify also provides business loans (between £3,500 and £500,000), but offers a key differentiator in allowing SMEs to repay loans daily in small increments, rather than facing large weekly or monthly repayments.

The Capify brand can point to a proven history of pioneering alternative financing ventures including being an early mover in the UK, US and Canada and the first to offer merchant cash advances in Australia. It achieved these successes whilst overcoming the global financial storm.

“Our official launch of Capify comes at an exciting time as the alternative financing industry is more prosperous than ever and is top of mind for everyone from those in Camden Town to Wall Street,” said founder David Goldin. “We’re proud to finally announce ourselves as one global conglomerate, that is one of the first international movers in the alternative finance space and the only alternative financing provider who can help small businesses with working capital solutions in the UK, US, Australia and Canada.”

Added Goldin, “By partnering with Capify, global companies that offer products and/or services to small and medium-sized businesses will now have a solution for providing their customers worldwide access to business capital.”

Both local and global companies that offer products and/or services to small and medium-sized businesses are now able to partner with Capify for a joint full-service solution that provides potential and current customers with the added benefit of worldwide access to business capital. International companies will also be able to test this out in one or two countries before leveraging in all four.

Capify’s technology platform offers a real-time online application for small and medium-sized businesses. This technology allows applicants to receive real-time decisions in 60 seconds or less and working capital approval amounts powered by 10+ years of proprietary merchant performance data. Capify also provides an API for websites looking to integrate its online application directly.

Capify is poised to continue its growth with expansion into new markets with the upcoming announcement of several large strategic partnerships. To find out more visit www.capify.co.uk

Media Contact:

Simon Ward
+44 (0)7803204779
simon@skyparlour.com
www.capify.global, www.capify.co.uk

SOURCE: Capify

ReleaseID: 430753